aap continues to be on target with a double-digit growth in sales (+10 %) in the first half of 2011
(Thomson Reuters ONE) -
aap Implantate AG /
aap continues to be on target with a double-digit growth in sales (+10 %) in the
first half of 2011
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
According to preliminary figures, aap Implantate AG, a medical technology
company listed in the Prime Standard segment of the Frankfurt stock exchange
achieved a growth in sales on product level of 10% to EUR 14.1 million in the
first half of the 2011 fiscal year (previous year: EUR 12.8 million).The growth
compared to the last six months of the previous year is mainly the result of
increased sales in the fields of cement and cementing techniques as well as
contract manufacturing. Compared to the last quarter of the previous year, the
sales in the second quarter of 2011 rose from EUR 7.0 million to EUR 7.6
million (+ 9%).
Our innovative and IP-protected WSG product system was successfully launched at
the end of June, with the placement of the first systems in leading German
trauma hospitals. Consequently, the scheduled launch with respect to the WSG
products for trauma applications was achieved; initial sales are expected over
the course of the third quarter. The international roll-out is scheduled for the
third quarter of 2011.
In addition, the first deliveries of our latest antibiotic-containing collagen
fleece to a leading international orthopaedic company were executed in the
second quarter.
We hope to power the sales development throughout the remainder of the year
2011 with the launch of the new WSG product system and the introduction of
existing and new products on new/existing markets. Aside from continuing to
simplify the corporation-wide structure, we strive to optimize our IT division
through international networking and standardization.
aap is planning to publish the complete quarterly report Q2/2011 on August
10, 2011.
______________
aap Implantate AG (ISIN DE0005066609)
- Prime Standard/Regulated Market - All German stock markets -
aap is a medical technology company that develops, manufactures and markets
biomaterials and implants for the areas Ortho/Trauma/Spine. Its product
portfolio includes bone cements, bone graft substitutes, antibiotic carriers,
and implants for fracture healing and joint replacement. In addition to its
Berlin HQ the Company has sites in Dieburg near Frankfurt am Main and Nijmegen
in the Netherlands. aap Implantate AG stock has been listed in the Prime
Standard segment of the Frankfurt Stock Exchange since May 16, 2003.
For inquiries please contact:
aap Implantate AG, Nanette Huedepohl, Head of Corporate Communications,
Lorenzweg 5, 12099 Berlin, Germany, Tel.: +49 30 7501 9133, fax:
+49 30 7501 9290, n.huedepohl(at)aap.de
For more details please visit www.aap.de
--- End of Message ---
aap Implantate AG
Lorenzweg 5 Berlin Germany
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: aap Implantate AG via Thomson Reuters ONE
[HUG#1528607]
Unternehmensinformation / Kurzprofil:
Datum: 05.07.2011 - 19:07 Uhr
Sprache: Deutsch
News-ID 56153
Anzahl Zeichen: 4240
contact information:
Town:
Berlin
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 133 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"aap continues to be on target with a double-digit growth in sales (+10 %) in the first half of 2011"
steht unter der journalistisch-redaktionellen Verantwortung von
aap Implantate AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
